Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.1K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional disease progression in children with inherited peripheral neuropathies: A prospective cohort study.

Journal of neuromuscular diseases·2026
Same author

Efficacy and safety of risdiplam in patients with type 1 spinal muscular atrophy: a 3-year open-label extension of the two-part, phase 2 FIREFISH trial.

The Lancet. Child & adolescent health·2026
Same author

Association of behavioral problems and health-related quality of life in children with epilepsy.

Epilepsy & behavior : E&B·2026
Same author

ALARA+: Summit on Radiation and Orthopedic Risks in Fluoroscopic Laboratories.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same author

Pediatric meningoencephalitis in the molecular diagnostic era: epidemiological insights from 1198 suspected cases in Germany between 2016 and 2024.

Infection·2026
Same author

Editorial Expression of Concern: YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity.

Oncogene·2026

Related Experiment Video

Updated: Oct 16, 2025

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

24.7K

[Newborn screening program for spinal muscular atrophy].

Heike Kölbel1, Katharina Vill2, Oliver Schwartz3

  • 1Klinik für Kinderheilkunde, Kinderklinik 1/Neuropädiatrie, Universitätsmedizin Essen (UME), Hufelandstr. 55, Essen, Deutschland. heike.koelbel@uk-essen.de.

Der Nervenarzt
|October 15, 2021
PubMed
Summary
This summary is machine-generated.

Germany

Keywords:
5q-SMAConfirmation diagnosticsPresymptomatic treatmentSMN proteinSMN2 copy number

More Related Videos

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

13.9K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.7K

Related Experiment Videos

Last Updated: Oct 16, 2025

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

24.7K
Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

13.9K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.7K

Area of Science:

  • Genetics
  • Neurology
  • Pediatrics

Background:

  • Germany is implementing a newborn screening program for 5q-spinal muscular atrophy (SMA) in late 2021.
  • Advances in targeted therapies offer new treatment options for all SMA patients.

Purpose of the Study:

  • To present insights from pilot newborn screening projects for 5q-SMA in Germany.
  • To discuss the advantages and disadvantages of implementing a nationwide SMA screening program.

Main Methods:

  • Newborn screening for 5q-SMA utilizes molecular genetic analysis of dried blood spots to detect homozygous deletion of SMN1 exon 7.
  • Confirmation diagnostics involve a second blood sample to determine SMN2 copy numbers.

Main Results:

  • Pilot projects in Germany provided valuable data on the feasibility and outcomes of SMA newborn screening.
  • Key advantages and disadvantages of the screening approach were identified and analyzed.

Conclusions:

  • Early detection through newborn screening enables timely intervention for 5q-SMA.
  • Treatment should be managed by neuropediatric departments experienced in 5q-SMA, ensuring access to all therapeutic options.
  • Initiating treatment within the first month of life is crucial for optimal outcomes in infants with 5q-SMA.